Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,237,303 papers from all fields of science
Search
Sign In
Create Free Account
Prostate cancer, familial
Known as:
Hereditary prostate cancer
, PRCA1
, HPC1
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
HPC1 gene
Broader (1)
Prostatic Neoplasms
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2015
Highly Cited
2015
Photo- and thermochromic and adsorption properties of porous coordination polymers based on bipyridinium carboxylate ligands.
O. Toma
,
N. Mercier
,
+4 authors
I. Bezverkhyy
Inorganic Chemistry
2015
Corpus ID: 38104097
The zwitterionic bipyridinium carboxylate ligand 1-(4-carboxyphenyl)-4,4'-bipyridinium (hpc1) in the presence of 1,4…
Expand
Highly Cited
2007
Highly Cited
2007
Polycomb-group oncogenes EZH2, BMI1, and RING1 are overexpressed in prostate cancer with adverse pathologic and clinical features.
G. V. van Leenders
,
D. Dukers
,
+6 authors
F. Raaphorst
European Urology
2007
Corpus ID: 2782496
Highly Cited
2003
Highly Cited
2003
Effects of RNase L mutations associated with prostate cancer on apoptosis induced by 2',5'-oligoadenylates.
Y. Xiang
,
Zhengfu Wang
,
+7 authors
R. Silverman
Cancer Research
2003
Corpus ID: 8891152
The RNASEL gene, a strong candidate for the hereditary prostate cancer 1 allele (HPC1), encodes a single-stranded specific…
Expand
Highly Cited
2001
Highly Cited
2001
Evaluation of linkage and association of HPC2/ELAC2 in patients with familial or sporadic prostate cancer.
Jianfeng Xu
,
S. Zheng
,
+17 authors
W. Isaacs
American Journal of Human Genetics
2001
Corpus ID: 34180912
To investigate the relationship between HPC2/ELAC2 and prostate cancer risk, we performed the following analyses: (1) a linkage…
Expand
Highly Cited
2000
Highly Cited
2000
Recruitment experience in the first phase of the African American Hereditary Prostate Cancer (AAHPC) study.
C. Royal
,
A. Baffoe-Bonnie
,
+25 authors
F. Collins
Annals of Epidemiology
2000
Corpus ID: 21395156
Review
2000
Review
2000
No evidence of germline PTEN mutations in familial prostate cancer
M. S. Forrest
,
S. Edwards
,
+12 authors
The Crcbpg UK Familial Prostate Cancer Study Collaborators
Journal of Medical Genetics
2000
Corpus ID: 39337595
Editor—Cystic fibrosis (CF) is one of the most common autosomal recessive disorders, with an incidence of one in every 2000 to…
Expand
Highly Cited
2000
Highly Cited
2000
Combined analysis of hereditary prostate cancer linkage to 1q24-25: results from 772 hereditary prostate cancer families from the International Consortium for Prostate Cancer Genetics.
Jianfeng Xu
American Journal of Human Genetics
2000
Corpus ID: 29835085
A previous linkage study provided evidence for a prostate cancer-susceptibility locus at 1q24-25. Subsequent reports in…
Expand
Highly Cited
1998
Highly Cited
1998
Evidence for a prostate cancer susceptibility locus on the X chromosome.
Jianfeng Xu
,
D. Meyers
,
+40 authors
J. Trent
Nature Genetics
1998
Corpus ID: 1534990
Over 200,000 new prostate cancer cases are diagnosed in the United States each year, accounting for more than 35% of all cancer…
Expand
Highly Cited
1997
Highly Cited
1997
Prostate cancer susceptibility locus on chromosome 1q: a confirmatory study.
Kathleen A. Cooney
,
Jenifer D. McCarthy
,
+6 authors
Kenneth Lange
Journal of the National Cancer Institute
1997
Corpus ID: 32343752
Highly Cited
1997
Highly Cited
1997
Interference with the expression of a novel human polycomb protein, hPc2, results in cellular transformation and apoptosis
D. Satijn
,
Daniel J. Olson
,
+11 authors
A. Otte
Molecular and Cellular Biology
1997
Corpus ID: 35001836
Polycomb (Pc) is involved in the stable and heritable repression of homeotic gene activity during Drosophila development. Here…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE